Robert J. Schott - SVP, Head of Development at Sangamo Therapeutics, Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Head of Development
Stock Symbol
SGMO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert J. Schott since 9/17/2023

Holdings reported by Robert J. Schott for Sangamo Therapeutics, Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 75.5K $28.9K $0.38 Feb 25, 2022 Direct
Stock Option (Right to Buy) 111K Feb 25, 2022 Direct Common Stock

Transactions reported by Robert J. Schott for Sangamo Therapeutics, Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.